[Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease]

[Article in Polish]

Review

[Article in Polish]

J Gryglik. Pol Tyg Lek. 1979.

. 1979 Mar 26;34(13):509-11.

No abstract available

Similar articles

Status of antiplatelet drugs in coronary heart disease.
Mehta J, Mehta P. Mehta J, et al. JAMA. 1979 Jun 15;241(24):2649-51. JAMA. 1979. PMID: 439365 No abstract available.
[Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
Caruzzo C, Belli R, Biasci R, Gaschino G, Bruna C. Caruzzo C, et al. Minerva Cardioangiol. 1979 Jun;27(6):367-72. Minerva Cardioangiol. 1979. PMID: 38413 Clinical Trial. Italian. No abstract available.
[Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA, Savenkov MP. Liusov VA, et al. Ter Arkh. 1988;60(8):55-9. Ter Arkh. 1988. PMID: 3227479 Russian. No abstract available.
Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS. Gallus AS. Med J Aust. 1985 Jan 7;142(1):41-7. Med J Aust. 1985. PMID: 3880861 Review.
[Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M. Verstraete M. Clin Ter. 1979 Oct 31;91(2):117-27. Clin Ter. 1979. PMID: 396098 Review. Italian. No abstract available.